Surgery Partners announced the acquisition of Preferred Vascular Group (PVG), a specialty ambulatory surgery center operator that focuses on dialysis access procedures. The deal adds eight PVG ASCs located in Georgia and Ohio to Surgery Partners’ national network, extending the company’s presence in the $6 billion dialysis‑access market and adding a high‑volume, low‑margin niche to its portfolio.
The acquisition is a strategic move that complements Surgery Partners’ existing orthopedic and general surgery centers. By adding dialysis‑access procedures, the company diversifies its revenue streams and gains exposure to a market that performs over two million procedures annually, offering scale potential while maintaining its short‑stay surgical model.
PVG’s management will continue to lead the operating entity, and the transaction terms were not disclosed. The integration plan is expected to leverage Surgery Partners’ national network to enhance operational efficiency and expand PVG’s reach, though specific synergy targets remain unannounced.
Surgery Partners’ recent financial performance provides important context for the deal. The company reported a Q4 2025 earnings miss, with adjusted earnings per share of $0.12 versus a consensus estimate of $0.30, and issued a cautious 2026 guidance that fell short of analyst expectations. Despite these headwinds, the company authorized a $200 million share‑repurchase program, signaling confidence in its long‑term value.
The market reaction to the announcement was tempered by the company’s recent earnings miss and cautious guidance. While the acquisition itself was viewed as a positive strategic expansion, investors focused on the broader financial picture, which dominated the overall sentiment.
"The successful outcome, selling to a publicly traded and nationally scaled short‑stay surgical platform, was the optimal outcome that would not have been possible without the partnership between Preferred Vascular Group and Ziegler," said Dustin Greene, CEO of PVG.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.